1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Drug Delivery Systems Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Drug Delivery Systems Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Drug Delivery Systems Market Regional Analysis
6.2 North America Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)
6.3 North America Drug Delivery Systems Market Forecast Analysis
7. North America Drug Delivery Systems Market Analysis – by Route of Administration
7.1 Transmucosal
- 7.1.1 Overview
- 7.1.2 Transmucosal: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.2 Oral
- 7.2.1 Overview
- 7.2.2 Oral: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.3 Injectable
- 7.3.1 Overview
- 7.3.2 Injectable: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.4 Topical
- 7.4.1 Overview
- 7.4.2 Topical: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.5 Implantable
- 7.5.1 Overview
- 7.5.2 Implantable: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
7.6 Ocular
- 7.6.1 Overview
- 7.6.2 Ocular: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. North America Drug Delivery Systems Market Analysis – by Distribution Channel
8.1 Hospital Pharmacies
- 8.1.1 Overview
- 8.1.2 Hospital Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Retail Pharmacies
- 8.2.1 Overview
- 8.2.2 Retail Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.3 Online Pharmacies
- 8.3.1 Overview
- 8.3.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. North America Drug Delivery Systems Market Analysis – by Application
9.1 Home Care Settings
- 9.1.1 Overview
- 9.1.2 Home Care Settings: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
9.2 Hospitals & Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals & Clinics: North America Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)
10. North America Drug Delivery Systems Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Drug Delivery Systems Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.2.1.1 North America Drug Delivery Systems Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.2.1.1.2 US: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.2.1.1.3 US: North America Drug Delivery Systems Market Breakdown, by Application
- 10.2.1.2 Canada:
North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.2.1.2.2 Canada: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.2.1.2.3 Canada: North America Drug Delivery Systems Market Breakdown, by Application
- 10.2.1.3 Mexico :
North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Drug Delivery Systems Market Breakdown, by Route of Administration
- 10.2.1.3.2 Mexico : North America Drug Delivery Systems Market Breakdown, by Distribution Channel
- 10.2.1.3.3 Mexico : North America Drug Delivery Systems Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Novo Nordisk A/S
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 3M
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Boston Scientific Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bausch Health Companies Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Baxter International, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Boehringer Ingelheim
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novartis AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Johnson & Johnson Services, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Drug Delivery Systems Market
